Mitsubishi UFJ Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-62,500
Closed -$6.28M – 1152
2021
Q4
$6.28M Hold
62,500
– – 0.03% 543
2021
Q3
$7.81M Buy
62,500
+13,400
+27% +$1.59M 0.04% 462
2021
Q2
$6.1M Buy
49,100
+17,400
+55% +$2.34M 0.03% 514
2021
Q1
$4.84M Buy
31,700
+15,700
+98% +$2.37M 0.03% 515
2020
Q4
$2.06M Buy
16,000
+4,400
+38% +$506K 0.02% 649
2020
Q3
$1.3M Hold
11,600
– – 0.01% 678
2020
Q2
$941K Sell
11,600
-3,900
-25% -$314K 0.01% 690
2020
Q1
$1.08M Buy
15,500
+2,300
+17% +$176K 0.02% 605
2019
Q4
$1.03M Buy
+13,200
New +$951K 0.01% 693

Other funds holding GH

Mitsubishi UFJ Asset Management's GH Position: Q1 2022 in Review

Mitsubishi UFJ Asset Management sold out of Guardant Health (GH) in Q1 2022, closing a stake of 62,500 shares — an estimated $6.28M sold.

Mitsubishi UFJ Asset Management first reported a position in GH in Q4 2019 and held it in 9 quarters. The position peaked at $7.81M in Q3 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Mitsubishi UFJ Asset Management reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 62,500 Guardant Health shares in Q1 2022, an estimated $6.28M.
  • Mitsubishi UFJ Asset Management first reported a position in Guardant Health in Q4 2019 and held it in 9 quarters.
  • Mitsubishi UFJ Asset Management's Guardant Health position peaked at $7.81M in Q3 2021.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2022, filed 9 May 2022.